Spark Therapeutics Aktie

Spark Therapeutics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A12HQS / ISIN: US84652J1034

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
03.04.2019 07:14:02

Roche Withdraws Premerger Notification On Pending Acquisition Of Spark

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and Spark Therapeutics, Inc. (ONCE) announced Wednesday that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act in connection with Roche's pending acquisition of Spark.

Roche and Spark both filed a Premerger Notification and Report Form under the HSR Act on March 1, 2019 with respect to the pending acquisition. On March 18, Roche withdrew the March 1 filing and refiled a Premerger Notification and Report Form.

Roche has withdrawn the March 18 filing effective on April 2, and intends to refile a Premerger Notification and Report Form under the HSR Act on or about April 10.

Following such refiling, the waiting period applicable to the pending acquisition will expire at 11:59 p.m., New York City time, on or about April 25.

Nachrichten zu Spark Therapeutics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Spark Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!